Reduction of alpha-synuclein oligomers in preclinical models of Parkinson’s disease by electrical stimulation in vitro and deep brain stimulation in vivo
Background: Deep brain stimulation (DBS) has been widely used to manage debilitating neurological symptoms in movement disorders such as Parkinson's disease (PD). Despite its well-established symptomatic benefits, our understanding of the mechanisms underlying DBS and its possible effect on the accu...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier
2024-03-01
|
| Colección: | Brain Stimulation |
| Materias: | |
| Acceso en línea: | http://www.sciencedirect.com/science/article/pii/S1935861X24000160 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
